Yashoda Medicity’s AI-enabled E- ICU poised to make Quality Critical Care Universal

Super Specialty Hospital hosts discussion with GE Leaders to expand reach

Delhi/NCR: A mother’s compassion knows no bounds. Bearing the name of an iconic mother, Yashoda Medicity also wants to embrace whoever wherever might be in need of quality critical care that the facility is renowned for. As technological innovation has made it possible, Medicity’s AI-enabled E-ICU is all poised to make real time critical care monitoring universal to save lives in far off places. ECG data from GE Healthcare will be a vital component of this ambitious project

Patients in critical condition in distant clinics and hospitals will avail of the same quality monitoring and care if they would have been in Yashoda Medicity. The discussion with leaders of GE Healthcare and Wipro GE Healthcare on June 16th was to set the roadmap for making E-ICU universal.

Yashoda Medicity is forever pushing the envelope to make quality care continuum a reality.  The meeting of minds focused on further healthcare innovations to make quality care accessible and affordable. It pivoted around GE Healthcare’s Make in India initiative and priorities of expanding access to affordable and advanced healthcare solutions were shared. The interaction especially rivetted on extension of already operational AI-enabled E-ICU Command Centre at Yashoda Medicity through the proposed integration of ECG data from GE Healthcare, strengthening real-time critical care monitoring and response capabilities.

The E-ICU ecosystem will enable real-time transmission of ECG diagnostic data from clinics and hospitals to a centralized command center at Yashoda Medicity, where specialists can review reports instantly and guide the on-ground team in case of urgent alerts without delay, ensuring timely clinical intervention within the critical hour.

Operating on a hub-and-spoke framework, the model is aimed at strengthening continuity of care and improving outcomes through immediate reporting and expert oversight. Both organizations also discussed the future roadmap of scaling the AI-enabled E-ICU Command Centre to extend its reach to underserved and remote regions, further advancing the mission of accessible, technology driven healthcare.

Dr. Upasana Arora, Managing Director, Yashoda Medicity, said, “It was a valuable interaction with the leadership of GE Healthcare and Wipro GE Healthcare. Our long-standing collaboration reflects a shared vision of advancing technology-led healthcare solutions that enhance clinical capabilities and improve access to high-quality care.”

Senior leadership from GE Healthcare and Wipro GE Healthcare had arrived at the super specialty facility for this strategic interaction focused on advancing healthcare innovation and strengthening the 35-year partnership between Yashoda Group of Hospitals and Wipro GE Healthcare.  The delegation included Ms. Catherine Estrampes, Chief Commercial & Growth Officer, GE Healthcare, Mr. Raghavendra Rao V.S., Chief Operating Officer, Distribution, Wipro GE Healthcare and Ms. Ritu Maheshwari, Secretary of Department of Medical Health and Family Welfare of Uttar Pradesh. During their Visit they met Dr. P.N. Arora, Chairman and Managing Director, Yashoda Medicity, Dr. Upasana Arora, Managing Director, Yashoda Medicity, along with senior leadership and clinicians at Yashoda Medicity.

Related Posts

Medicines that cure Us are making Our Environment Sick

Antimicrobial Resistance Campaigner makes a Fervent Appeal for Safe Disposal of Leftover Medicines New Delhi: We invariably worry about what might be the side effects of medicines on our body…

ZEN- G packs a punch in Organ Donation as Over 500 Students pledge Organs

National Organ Transplant Games2026 set World Record in Talkatora Indoor Stadium New Delhi: The National Organ Transplant Games began on a high note in Talkatora Indoor Stadium on November 1,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

Stents to syringes: Serious harm reports surge, but makers remain unnamed

Stents to syringes: Serious harm reports surge, but makers remain unnamed

NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

Medicines that cure Us are making Our Environment Sick

Medicines that cure Us are making Our Environment Sick